Identification of the absorbed components and metabolites of Xiao-Ai-Jie-Du decoction and their distribution in rats using ultra high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

• Published in: Journal of pharmaceutical and biomedical analysis 2020-02, Vol.179, p.112984, Article 112984
• Main Authors: Fan, Huisen, Liu, Shijia, Shen, Weixing, Kang, An, Tan, Jiani, Li, Liu, Liu, Xiao, Xu, Changliang, Xu, Xuefen, Lai, Yueyang, Cheng, Haibo, Sun, Dongdong
• Format: Article
• Language: English
• Subjects: Absorbed components; Acids - analysis; Animals; Chromatography, High Pressure Liquid - methods; Drugs, Chinese Herbal - chemistry; Drugs, Chinese Herbal - pharmacokinetics; Flavonoids - analysis; Identification; Male; Metabolites; Rats; Saponins - analysis; Tandem Mass Spectrometry - methods; Tissue Distribution; Triterpenes - analysis; UHPLC-Q-TOF-MS; Xiao-Ai-Jie-Du formula
• ISSN: 0731-7085; 1873-264X
• DOI: 10.1016/j.jpba.2019.112984

•Identification of chemical constituents from XAJDD using a UPLC-Q-TOF/MS method.•Flavonoids, triterpenoids, organic acids, and steroidal saponins, are the main components in XAJDD.•The absorbed constituents in XAJDD were firstly summarized.•Metabolites identification and their tissue distribution of XAJDD in Rats. Xiao-Ai-Jie-Du decoction (XAJDD), a traditional Chinese medicine formula, has long been used for the treatment of hepatocarcinoma, gastric cancer and colorectal cancer. It is composed of six herbal medicines, including Scutellariae Barbatae Herba, Pseudostellariae Radix, Ophiopogonis Radix, Cremastrae Pseudobulbus, Curcumae Rhizoma and Akebiae Fructus. Despite the in-depth study on its pharmacological effects on cancer prevention and treatment, the comprehensive analysis of the chemical components and the absorbed bioactive constituents are not well studied. Thus, an ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS) method was established to detect and identify the chemical constituents in XAJDD. The absorbed components and metabolites after oral administration of XAJDD in rats were also studied. In total, 102 components were identified or tentatively characterized in XAJDD, including 30 flavonoids, 19 triterpenoids, 12 organic acids, 9 steroidal saponins, 9 cyclic peptides, 7 phenanthrenes, 5 amino acids, 3 alkaloids and 8 other compounds. After analysing the metabolites in rat plasma and urine after oral administration of XAJDD, a total of 70 compounds were identified, including 15 primary components and 55 metabolites, and metabolic pathways, including hydrogenation, hydroxylation, methylation, sulfonation, and glucuronidation were evaluated. Among these, methylation and glucuronidation were the main metabolic pathways. In conclusion, the developed UHPLC-Q-TOF-MS method with high sensitivity and resolution is suitable for identifying and characterizing the chemical constituents of XAJDD in vitro and characterizing the primary components and their metabolites in vivo; moreover, the results will provide essential data for further studying the relationship between the chemical components and pharmacological activity of XAJDD.